BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1612960)

  • 1. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH; Urano M
    Int J Radiat Oncol Biol Phys; 1992; 23(3):593-8. PubMed ID: 1612960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M; Wong KH; Reynolds R; Begley J
    Int J Hyperthermia; 1995; 11(3):379-88. PubMed ID: 7636324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
    Wong KH; Zhang H; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH; Maezawa H; Urano M
    Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT; Dembs N
    Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
    Wallen CA; Moore SK; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP; Hirst DG; Brown JM
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
    Urano M; Kim MS; Kahn J; Kenton LA; Li ML
    Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
    Mao HS; Grau C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(1):115-22. PubMed ID: 1727107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effect of 1,3 bis (2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumour response.
    Urano M; Majima H; Miller R; Kahn J
    Int J Hyperthermia; 1991; 7(3):499-510. PubMed ID: 1919145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.